Neocis, a Miami-based developer of advanced surgical robots, has secured $20 million in a recent funding round to further develop its flagship product Yomi and expand its market reach. Yomi is the first and only robot-assisted dental surgery system cleared by the FDA for implant procedures and bone reduction surgery.

This latest cash infusion comes on the heels of rapid adoption of Yomi by dental practices across the country. To date, over 40,000 dental implants have been placed using Yomi's precision guidance technology. The company expects use to accelerate, with a new dental implant placed every 6 minutes using the system.

"This funding positions us for continued success in the market and will help us drive meaningful innovation in implant dentistry," said Neocis co-founder and CEO Alon Mozes. "It's a testament to how far dental robotics has come since we installed the first Yomi systems."

Robotic Precision for Dental Implants

Neocis designed Yomi specifically for dental implantation procedures. The system guides the surgeon's hand during critical phases of surgery, providing haptic feedback and on-screen visual cues. This augments the physician's expertise, meaning the doctor remains fully in control while benefiting from Yomi's guidance.

The robot also integrates with Neocis' implant planning software, YomiPlan. Together, the technologies streamline the full implant workflow - from diagnosis and treatment planning to surgical execution. Neocis believes this integrated robotic approach can improve precision, efficiency and patient outcomes.

Early results seem to validate the benefits of robot-assisted dental surgery. Yomi has enabled dentists to perform procedures with minimally invasive incisions and high accuracy, reducing recovery times and complications for patients.

More Funding to Meet Growing Demand

Citing Yomi's clinical impact, investors led by Mirae Asset Financial Group and NVentures committed $20 million to further product development and expanded use.

"Robotics and AI are changing the face of dentistry, enabling innovations that increase doctor efficiency and help them improve quality of life for patients," said Mohamed Siddeek of NVentures. "Neocis is transforming dental implant procedures."

Neocis will leverage the funds to accelerate sales, train new dentists on the system, and collect more clinical data to support future regulatory clearances.

"We're tremendously grateful to have the backing of our newest investors, as well as our existing partners," said CEO Alon Mozes. "Together we will drive innovation in implant dentistry and get Yomi into more provider hands."

With ever-growing demand for dental implants, Neocis aims to cement robot-assisted surgery as a new standard of care. If initial reception is any indication, Yomi may soon become as common in dentist offices as the iconic dentist's chair.